PDX-1 Is a Therapeutic Target for Pancreatic Cancer, Insulinoma and Islet Neoplasia Using a Novel RNA Interference Platform

Shi‐He Liu(Baylor College of Medicine), F. Charles Brunicardi(Baylor College of Medicine)
PLoS ONE
August 8, 2012
Cited by 27


Related Papers